SC

Sushil Chander

Active Director Director DIN 01445120
DIN 01445120 First appointment Jan 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2007
Shareholding value •••• Premium profile

About Sushil Chander

Data last updated:

Sushil Chander is a Director at Emergent Pharma Private Limited (since 2007). The company operates in Pharma. Emergent Pharma Private Limited reported revenue of ₹3.72 Cr (FY 2015).

DIN 01445120
Primary Designation Director
Industry Pharma
First Appointment 05 Jan 2007
Oldest Company Age 19 yrs
Largest company Emergent Pharma Private Limited · ₹3.72 Cr (FY 2015)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Emergent Pharma Private Limited U24232CH2007PTC030663
Director05 Jan 20072007₹3.72 Cr (FY 2015)Active

Board colleagues of Sushil Chander

NameDINCompanyDesignation
Naresh Kumar01463180Emergent Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Emergent Pharma Private Limited
Premium access

Shareholding and investment profile for Sushil Chander

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sushil Chander

Sushil Chander currently holds 1 directorship: Emergent Pharma Private Limited (Director, since 05 Jan 2007, revenue ₹3.72 Cr (FY 2015)).

Sushil Chander was first appointed on 05 Jan 2007 as Director at Emergent Pharma Private Limited.

The current boards of Sushil Chander's companies include Naresh Kumar (Emergent Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available